Compare Amphastar Pharmaceuticals Inc (AMPH) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs State Street Technology Select Sector SPDR ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.87 (market cap $868.62M), while State Street Technology Select Sector SPDR ETF trades at $189.37. The key difference: State Street Technology Select Sector SPDR ETF is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | XLK | |
|---|---|---|
Market Cap | $868.62M | — |
Sector | Health | Sector/Thematic |
52-Week High | $30.81 | $198.21 |
52-Week Low | $16.87 | $127.49 |
Enterprise Value | $1.27B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $19.87, down 2.19% today, with a bullish technical signal from moving averages and ADX indicators. The company reported Q2 2026 EPS of $0.91, beating expectations, but missed in Q4 2025 and Q1 2026. Revenue for 2025 was $719.89M with a net income margin of 10.76%, while valuation ratios like P/E of 12.08 and EV/EBITDA of 6.57 suggest reasonable pricing. Recent news highlights growth from new product launches and ongoing FDA compliance efforts.
The outlook is mixed with growth opportunities from proprietary drugs and biosimilars, but risks include regulatory scrutiny and earnings volatility. Analyst sentiment is cautious with 25% buy ratings, reflecting concerns over execution and market pressures. Investors should weigh solid cash flow generation against competitive and regulatory headwinds for balanced exposure.
XLK trades at $188.97, up 1.42% on the day, with a bullish technical signal from moving averages and strong sector inflows. The technology sector is benefiting from robust earnings and AI-driven growth, though the ETF faces competition from alternatives like IGM that offer broader exposure at lower valuations. Recent news highlights record inflows into tech ETFs and strong corporate earnings, particularly from key holdings like Microsoft.
Outlook remains positive given sector momentum and earnings strength, but risks include high concentration in mega-cap stocks and potential valuation concerns. The ETF's performance is closely tied to a few large constituents, making diversification a key consideration for investors seeking tech exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About State Street Technology Select Sector SPDR ETF
XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →
